NDAINJECTIONINJECTABLE
Approved
Jun 2011
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
19
Mechanism of Action
[ see Clinical Pharmacology ( ) ].
Indications (22)
the following infections caused by designated susceptible Gram-negative microorganisms in adultused in combination with metronidazole ( ) Complicated Urinary Tract Infections (cUTI)including Pyelonephritis ( ) Hospital-acquired Bacterial PneumoniaVentilator-associated Bacterial Pneumonia (HABP/VABP) ( ) To reduce the development of drug-resistant bacteriamaintain the effectiveness of AVYCAZother antibacterial drugsAVYCAZ should be used only to treatprevent infectionsstrongly suspected to be caused by susceptible bacteriacomplicated intra-abdominal infections (cIAI) in adultKlebsiella pneumoniaeProteus mirabilisEnterobacter cloacaeKlebsiella oxytocaCitrobacter freundii complexPseudomonas aeruginosacomplicated urinary tract infections (cUTI) including pyelonephritis in adulthospital-acquired bacterial pneumoniaventilator-associated bacterial pneumonia (HABP/VABP) in adultEscherichia coliSerratia marcescensHaemophilus influenzae
Clinical Trials (5)
Safety, Pharmacokinetics and Efficacy of BV100 Plus Low Dose Polymyxin B Plus Ceftazidime/Avibactam, or Plus Cefiderocol in Patients With Pulmonary and Extrapulmonary Infections Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex
Started Jul 2026
120 enrolled
Ventilator Associated Bacterial Pneumonia (VABP)Hospital Acquired Bacterial Pneumonia (HABP)Blood Stream Infection+2 more
EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics
Started Dec 2023
1,900 enrolled
Blood Stream InfectionsVentilator Associated PneumoniaHealthcare Associated Infection+2 more
Real-World Study of Ceftazidime Avibactam in China
Started Oct 2022
220 enrolled
Hospital Acquired PneumoniaVentilator Acquired PneumoniaComplicated Intra Abdominal Infections
Retrospective Analysis of Real World Use of Ceftazidime-avibactam in the Management of Gram Negative Infections
Started Jan 2021
189 enrolled
Gram Negative Infections
Single-dose PK Study of Ceftazidime-Avibactam In Hospitalized Children Receiving Systemic Antibiotics for Nosocomial Pneumonia
Started Jun 2020
4 enrolled
Hospitalized Children With Suspected or Confirmed Nosocomial Pneumonia